Cipla and Rocket India plan ₹300 crore Karnataka manufacturing expansion
Cipla will invest ₹200 crore to expand its Bommasandra facility, targeted to begin production by December, while plant-protein maker Rocket India will invest ₹100 crore to scale production in Gokak.
Cipla and plant-protein maker Rocket India plan Rs 300 crore of manufacturing expansion in Karnataka. Cipla is expanding its Bommasandra facility, while Rocket India will expand Gokak production with assured maize supply; Blackstone is evaluating state infrastructure investments.
Why this matters
The capacity plan extends Cipla’s recent India growth push after India sales rose 12% on consumer-health expansion, even as Q1FY27 profit fell 39% despite record India sales and the company prioritised Yurpeak over a semaglutide launch.
Retail-company signals are accelerating, up 163856% QoQ.